Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Ruvembri by Biophytis for Obesity: Likelihood of Approval
Ruvembri is under clinical development by Biophytis and currently in Phase I for Obesity. According to GlobalData, Phase I drugs...
Ruvembri by Biophytis for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Ruvembri is under clinical development by Biophytis and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia. According to...
Ruvembri by Biophytis for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome: Likelihood of Approval
Ruvembri is under clinical development by Biophytis and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory...